Clinical Trial Update: Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a rebeccamycin analogue for Stage IIIB or Stage IV breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer
• Stage Iiib Breast Cancer

Drugs mentioned

• Rebeccamycin analogue (rebeccamycin analogue)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED